Pasquale Valerio Falzone

Plain English
This study looked at how a technique called electrocardiographic imaging (ECGI) can help identify areas in the heart that may lead to dangerous heart rhythms in patients with ischemic cardiomyopathy (ICM). Researchers found that scarred areas of the heart showed significant differences in electrical activity compared to healthy areas, with a measurement called regional activation dispersion (rAD) being much higher in scarred regions (46.3 milliseconds versus 30.1 milliseconds) and signaling a higher risk of ventricular tachycardia (VT). These findings highlight that ECGI can be a valuable tool alongside traditional imaging to better assess the risk of dangerous heart rhythms in patients. Who this helps: This helps patients with ischemic cardiomyopathy and their doctors by providing better risk assessments for heart problems.

Plain English
This study looked at how deep scar tissue in the heart, as measured by cardiac magnetic resonance (CMR), affects the chance of ventricular tachycardia (VT) coming back after a specific treatment called endocardial ablation. The researchers analyzed data from 51 patients and found that a channel depth of more than 7.2 mm strongly predicted a recurrence of VT, having a 100% sensitivity rate, meaning it correctly identified all patients who would have a recurrence. This is important because it suggests that knowing the depth of heart scar tissue can help doctors decide whether to use a less invasive treatment method, potentially reducing the risks of more severe complications. Who this helps: This benefits patients with scar-related ventricular tachycardia by potentially leading to safer treatment options.

Plain English
The PAM-VT 2 study looked at how the heart scars and ablation sites change over time after patients undergo a procedure to treat abnormal heart rhythms called ventricular tachycardia (VT). Researchers followed 51 patients for an average of 3.1 years and found that while the core scar tissue increased, the surrounding border zone scar decreased over time. They also discovered that if patients had more than one path for electrical signals at the first follow-up scan, their chances of VT returning increased significantly—from 19.5% to 75.6%. Who this helps: This research benefits patients with ventricular tachycardia by improving post-treatment care and monitoring.

Plain English
This study looked at a treatment called Non-Endocardial Radiofrequency Ablation (NERA) for patients with frequent heartbeats known as premature ventricular complexes (PVCs). It involved 64 sites across 56 procedures between 2017 and 2023, achieving procedural success in 82% of cases, with a significant 97% reduction in PVCs during follow-up. The research found that while using high power and long duration radiofrequency was generally safe, treating multiple sites increased the chance of the procedure not working as well. Who this helps: This helps patients suffering from frequent PVCs by offering an effective treatment option.

Plain English
This study looked at two types of heart pacing—left bundle branch pacing (LBBP) and right ventricular (RV) pacing—in patients who had heart problems after a procedure called transcatheter aortic valve implantation (TAVI). Researchers followed 24 patients and found that both pacing methods had similar success rates in improving heart function, with about 33% of LBBP patients and 25% of RV patients experiencing benefits. However, patients with LBBP saw a notable improvement in heart rhythm speed, which could lead to better heart health overall. Who this helps: This helps patients with heart block after TAVI procedures.

Plain English
This study looked at patients who received a new type of defibrillator called a subcutaneous implantable cardioverter defibrillator (S-ICD) after their previous one (transvenous ICD, or TV-ICD) was removed due to problems like infection (64%) or lead malfunction (36%). Out of 36 patients followed for about 31 months, 8 people (22%) died, mainly from heart failure, and 7 others (19%) faced complications related to the new device. The findings show that the S-ICD is a good option for patients who need a replacement after lead extraction, with deaths primarily linked to existing health conditions rather than the new device itself. Who this helps: This helps patients requiring a defibrillator after complications from their previous device.

Plain English
This study looked at the results of 105 patients who received a subcutaneous implantable cardioverter defibrillator (S-ICD) using a specific two-incision technique over three years. The researchers found that 9.5% of patients had device-related complications and 8.5% experienced inappropriate shocks, with lead-related issues being the most frequent problems. This is important because it shows that this technique leads to few complications and effectively manages heart issues without impacting overall survival. Who this helps: This benefits patients with heart conditions who need defibrillators, as well as doctors who are implanting the devices.

Plain English
This study looked at how well cardiac magnetic resonance imaging (CMR) can identify areas in the heart that are involved in a fast heart rhythm called ventricular tachycardia (VT) before a procedure to treat it. Researchers studied 44 patients with heart issues and found that 76.1% of the detected heart channels linked to these problematic areas, called deceleration zones, were longer and had greater mass, indicating they are more likely to cause arrhythmias. This finding is important because it means CMR can effectively help doctors find specific targets for VT treatment without needing invasive procedures. Who this helps: This helps patients with ventricular tachycardia by improving treatment options.

Plain English
This research paper reviews the effectiveness of a procedure called catheter ablation for treating a fast heart rhythm known as ventricular tachycardia in patients with heart disease caused by lack of blood flow. Studies like PARTITA and PAUSE-SCD show that this procedure can significantly improve patient outcomes, with some trials indicating up to a 75% reduction in life-threatening events. New imaging and mapping techniques better guide the procedure, while emerging technologies promise even better results. Who this helps: Patients with ischemic heart disease at risk for severe heart rhythm problems.

Plain English
This study focused on whether patients can safely go home on the same day after a procedure to treat atrial fibrillation, which is an irregular heartbeat. It involved 420 patients, and of those, 331 were eligible for same-day discharge; 300 of them (91%) were successfully sent home the same day without major complications. This approach not only kept patients safe but also made hospital workflows more efficient and reduced complications related to the procedure. Who this helps: Patients undergoing atrial fibrillation ablation.

Plain English
This study looked at how personalized voltage maps, created using advanced heart imaging techniques, can improve the diagnosis and treatment of dangerous heart rhythms called ventricular tachycardia (VT). Researchers examined 32 patients and found that using these personalized maps increased the identification of important heart tissue areas—called deceleration zones—from 44.2% to 75.0%, and improved the detection of VT pathways from 35.5% to 74.2% compared to standard methods. This matters because better identification of these areas can lead to more effective treatments for patients at risk of serious heart problems. Who this helps: This helps patients with ventricular tachycardia, particularly those with heart scarring.

Plain English
This study looked at a method for treating a heart condition called ventricular tachycardia (VT) with a technique called substrate mapping. Researchers found that using a specific mapping approach (referred to as the S3 protocol) helped identify more trouble spots in the heart related to VT, leading to significantly better outcomes: after treatment, 77.9% of patients remained free from VT during a follow-up of about 14 months. This is important because improving the success rate of VT ablation can lead to better quality of life for patients with this serious heart issue. Who this helps: Patients with ventricular tachycardia.

Plain English
This study looked at the outcomes of a procedure called transvenous lead extraction (TLE) in patients aged 80 and older, specifically using advanced tools to help with the process. Out of 83 patients, the procedure was successful in 93.9% of cases, with a 30-day mortality rate of 6%. The findings show that, although older patients have higher risks of complications, the extraction can be done safely and effectively using specialized methods, helping doctors make better decisions about heart device removals for this age group. Who this helps: This research benefits elderly patients with heart devices, as well as their healthcare providers.

Plain English
This study looked at a 16-year-old boy who developed shortness of breath when active, which is a condition called exertional dyspnea, after having a chest injury from a motorbike accident two years prior. Despite having no other health issues or family history of heart problems, he experienced significant difficulty during physical activities, rated as Class II-III on a common scale for heart-related symptoms. Understanding these symptoms is important because they may indicate that previous injuries can have lasting effects on young people's heart and lung function. Who this helps: This information benefits young patients recovering from chest injuries and their doctors.

Plain English
This study examined the effectiveness of a specialized tool called the Evolution RL bidirectional rotational mechanical sheath for safely removing heart device leads from patients. It involved 84 patients, primarily men around 65 years old, and showed a high success rate, with 91.6% of procedures completed successfully and only 1.2% experiencing major complications. This is important because it highlights how teamwork between heart surgeons and specialists can improve patient care and outcomes, particularly for those with infections. Who this helps: This helps patients needing lead removal from heart devices, especially those with infections.

Plain English
This study looked at patients who were admitted to the hospital for serious heart issues during the COVID-19 outbreak in 2020, comparing them to patients admitted during the same time in 2019. While the number of admissions was similar (210 in 2020 vs. 207 in 2019), many more patients came to the hospital late after their symptoms started, and they faced more serious complications, like requiring urgent surgery (13% in 2020 vs. 5% in 2019) and longer hospital stays (median of 10 days in 2020 vs. 8 days in 2019). This matters because it highlights the impact of the pandemic on how quickly patients sought help for heart issues, affecting their recovery and treatment outcomes. Who this helps: This helps patients with cardiovascular diseases and their healthcare providers.

Plain English
This study looked at a new method for safely removing old heart device wires called leads, specifically those implanted in the jugular vein. The researchers found that using a bidirectional rotational mechanical sheath made it easier and safer to extract these leads. This is important because it can improve patient outcomes and reduce complications during the procedure. Who this helps: Patients with chronically implanted jugular leads.

Plain English
This study looked at the process of safely removing an older type of heart pacing lead called the His bundle pacing lead, which had been in place for over 14 years. The researchers successfully extracted this lead along with two others without causing harm to the heart's electrical system. This finding is important because it shows that removing old pacing leads can be done safely, even when they are very old and difficult to extract. Who this helps: This benefits doctors and patients who may need to have old heart pacing devices removed.